Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Laura Gálvez-Melero: How a Combination of Imipramine and Ticlopidine Could Be a Promising Option for Glioma Treatment
Laura Gálvez-Melero/LinkedIn
May 9, 2026, 14:46

Laura Gálvez-Melero: How a Combination of Imipramine and Ticlopidine Could Be a Promising Option for Glioma Treatment

Laura Gálvez-Melero, Phd Student at University of the Balearic Islands, shared a post on LinkedIn about an article by Ksenya Shchors, published in Cancer Cell, adding:

“Hiiii I’m back!

After taking a one-month break from sharing scientific content, I’m excited to return with more interesting papers and ideas, and of course my weekly questions!

Maybe some of you even missed it a little bit.

I think there isn’t a better way to come back than by sharing a research closely related to my thesis topic.

The study explores how a combination of Imipramine (a tricyclic antidepressant) and Ticlopidine (an anticoagulant) could be a promising option for glioma treatment.

And after this month, there’s an idea that concerns me…

We see a lot of science communication on social media every day, but what matters more nowadays: getting scientific information out quickly, or making sure it’s true”

Title: Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit

Authors: Ksenya Shchors, Aristea Massaras, Douglas Hanahan

Laura Gálvez-Melero

Stay updated on all scientific advances with Hemostasis Today.

Aristea Massaras Douglas Hanahan glioma treatment Health Hematology Hemostasis Hemostasis News Hemostasis Today imipramine Ksenya Shchors Laura Gálvez-Melero Medicine ticlopidine
NewsFeed